Hester Biosciences Ltd.

HESTERBIO

Market Cap
₹2,728 Cr.
P/E
144.41

Hester Biosciences Ltd.

About
Hester Biosciences Limited (Hester) is the largest poultry vaccine manufacturer and one of the leading animal healthcare companies in India. Incorporated in 1987, the company has come a long way from … Read more
Hester Biosciences Limited (Hester) is the largest poultry vaccine manufacturer and one of the… Read more
Low
1293
52W Range
High
3375
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
9.52%
3yr Average
13.24%
5yr Average
15.53%
Net Profit Margin
Latest
10.01%
3yr Average
14.27%
5yr Average
16.41%
ROCE
Latest
8.65%
3yr Average
12.7%
5yr Average
15.89%
Debt to Equity
Latest
0.96
3yr Average
0.76
5yr Average
0.68
Market Share
35 %
(as of Mar 24)
Source/Historic
Poultry Vaccines - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operating Profit Break-Up

Capex

Asset Break-Up - Segment

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    FAQs on Hester Biosciences Ltd. Business

    Hester Biosciences Limited, a premier animal healthcare company in India known for poultry vaccines. Established in 1987, it has become a top global manufacturer with Asia's largest animal biological manufacturing unit in Ahmedabad.

    Hester Biosciences major competitors are IOL Chem & Pharma, Solara Active Pharma, SMS Pharmaceuticals, Morepen Laboratories, Themis Medicare, Supriya Lifescience, NGL Fine-Chem.
    Market Cap of Hester Biosciences is ₹2,728 Crs.
    While the median market cap of its peers are ₹2,429 Crs.

    Hester Biosciences seems to be less financially stable compared to its peers.
    Altman Z score of Hester Biosciences is 5.37 and is ranked 5 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Jun Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Hester Biosciences Ltd.
    View the discussion on ValuePickr
    Business Analysis - Hester Biosciences - Value Educator
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline Timeline